tiprankstipranks
Kaken Pharmaceutical Co Ltd (KKPCF)
OTHER OTC:KKPCF
Holding KKPCF?
Track your performance easily

Kaken Pharmaceutical Co (KKPCF) Income Statement

4 Followers

Kaken Pharmaceutical Co Income Statement

Last quarter (Q3 2022), Kaken Pharmaceutical Co's total revenue was $18.75B, a decrease of -6.79% from the same quarter last year. In Q3, Kaken Pharmaceutical Co's net income was $3.19B. See Kaken Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 22Mar 21Mar 20Mar 19Mar 18
Total Revenue
$ 55.28B$ 76.03B$ 74.98B$ 89.23B$ 94.17B$ 98.43B
Cost of Revenue
$ 25.50B$ 34.46B$ 34.07B$ 38.75B$ 40.37B$ 42.41B
Gross Profit
$ 29.77B$ 41.58B$ 40.91B$ 50.48B$ 53.80B$ 56.03B
Operating Expense
$ 18.35B$ 24.51B$ 23.11B$ 23.97B$ 29.20B$ 28.53B
Operating Income
$ 11.42B$ 17.07B$ 17.79B$ 26.52B$ 24.60B$ 27.50B
Net Non Operating Interest Income Expense
$ -9.00M$ -11.00M$ -9.00M$ -10.00M$ -11.00M$ -11.00M
Other Income Expense
------
Pretax Income
$ 7.85B$ 13.88B$ 18.66B$ 26.59B$ 24.92B$ 27.69B
Tax Provision
$ 2.45B$ 4.34B$ 5.25B$ 7.22B$ 7.15B$ 8.64B
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 5.39B$ 9.55B$ 13.40B$ 19.37B$ 17.77B$ 19.04B
Basic EPS
$ 143.90$ 251.43$ 347.37$ 494.89$ 445.78$ 470.54
Diluted EPS
$ 143.45$ 251.43$ 347.37$ 494.89$ 445.78$ 470.54
Basic Average Shares
$ 114.88M$ 37.98M$ 38.59M$ 39.14M$ 39.87M$ 40.47M
Diluted Average Shares
$ 114.88M$ 37.98M$ 38.59M$ 39.14M$ 39.87M$ 40.47M
Dividend Per Share
$ 75.00$ 150.00$ 75.00$ 150.00$ 150.00$ 150.00
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 43.86B$ 58.97B$ 57.19B$ 62.72B$ 69.57B$ 70.93B
Net Income From Continuing And Discontinued Operation
$ 5.39B$ 9.55B$ 13.40B$ 19.37B$ 17.77B$ 19.04B
Normalized Income
$ 7.91B$ 12.06B$ 13.09B$ 19.63B$ 17.81B$ 19.16B
Interest Expense
$ 13.00M$ 17.00M$ 17.00M$ 17.00M$ 17.00M$ 16.00M
EBIT
$ 7.86B$ 13.90B$ 18.67B$ 26.61B$ 24.94B$ 27.70B
EBITDA
$ 7.86B$ 16.39B$ 20.99B$ 28.92B$ 27.09B$ 29.83B
Currency in USD

Kaken Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis